School of Medicine


Showing 1-6 of 6 Results

  • Atulkumar T. Shah, MD

    Atulkumar T. Shah, MD

    Clinical Instructor, Medicine - Gastroenterology & Hepatology

    Bio Dr. Shah is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care?s Digestive Health program. He is a clinical associate professor of medicine in the division of Gastroenterology and Hepatology at Stanford University School of Medicine.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    Dr. Shah treats all gastrointestinal and liver conditions, such as gastroesophageal reflux disease (GERD), colon polyps, hepatitis, inflammatory bowel disease, and irritable bowel syndrome. He has a special interest in the increasingly prevalent fatty liver disease, which allows him to work closely with patients to educate them about symptom management and making lifestyle changes that will improve their health and wellbeing.

    After more than two decades of practice, Dr. Shah added training in liver transplant to expand his knowledge of liver disease and offer his patients a ?one-stop? resource for truly comprehensive care.

    Dr. Shah is a member of the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy, and American Association for the Study of Liver Disease.

    Among Dr. Shah?s current research interests is the development of an algorithm assessing the impact of gastrointestinal disease management on readmission rates.

    Dr. Shah brings a personalized approach to working with patients and to teaching the next generation of physician scientists the classic skills of careful listening and patient examination. Throughout his career, he has emphasized the fundamental importance of balancing scientific expertise with empathy and compassion.

    As a volunteer with the non-profit organization Health Volunteers Overseas, Dr. Shah travels around the world to train physicians about liver disease management and treatment. He is director of the HVO site in Bangalore, India.

  • Sundeep Singh

    Sundeep Singh

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Bio After living and training throughout the country, I am excited to be part of the Stanford team. As a result of both my personal experiences and training, I am passionate about ensuring that patients receive appropriate diagnostic testing and treatment options in order to improve people's quality of life. In collaboration with my amazing colleagues, I am confident in the high quality and easily accessible care we are able to provide to patients across northern California.

    While my interest is most in inflammatory bowel disease, I am also interested in the interaction between mental health, incentives, and emerging therapies in gastroenterology.

  • Sidhartha Sinha

    Sidhartha Sinha

    Assistant Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center

    Current Research and Scholarly Interests There are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:

    (1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;

    (2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain).

  • Irene Sonu

    Irene Sonu

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    Bio I am passionate about gut health and strive to provide the best care to my patients. I specialize in complex motility disorders of the gastrointestinal tract. My areas of clinical expertise include achalasia, dysphagia, eosinophilic esophagitis, gastroesophageal reflux disease, gastroparesis, functional dyspepsia, irritable bowel syndrome, and pelvic floor dysfunction. I also see patients in need of fecal microbiota transplant for recurrent C. difficile infection.

  • Sarah Streett

    Sarah Streett

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Bio Dr. Sarah Streett is the Clinical Director of Inflammatory Bowel Disease at Stanford and is passionate about taking care of people with IBD. She is a national expert in the treating of complex IBD and is expanding our services to offer multi-disciplinary care and opportunities for clinical research participation. In 2018 she received the Champion of Hope Award from the Crohn?s and Colitis Foundation and serves on their Medical Advisory Board. Her interests are in fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and in the role that the microbiome and diet play its pathogenesis. She is one of the investigators in the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy and applying new technologies to individualizing therapy for IBD.

    Dr. Streett has a national leadership role in the American Gastroenterological Association, where has been Chair of the Practice Management and Economics Committee, as well as Chair of the AGA?s initiatives on Obesity. She currently serves on the Government Affairs Committee and is a special government employee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patient?s personalized care based on the latest therapies for the treatment of IBD.

Footer Links:

Stanford Medicine Resources: